Discover
DSGN
Design Therapeutics, Inc.
14.66
2 x 10.52
2 x 17.31
bid
ask
+
0.19
1.31%
2 @ 04:47 AM
14.42 -0.24 (1.64%)
| Ytd | 56.29% | |
| 1y | 316.48% |
13.54
day range
14.68
3.46
52 week range
17.25
| Open | 14.36 | Prev Close | 14.47 | Low | 13.54 | High | 14.68 | Mkt Cap | 915.62M |
| Vol | 1.21M | Avg Vol | 894.76K | EPS | -1.20 | P/E | N/A | Forward P/E | -5.13 |
| Beta | 1.83 | Short Ratio | 19.61 | Inst. Own | 56.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 12.54 | 200-d Avg | 9.91 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 19.71M | ||
| Research and Development Expense | 14.38M | ||
| Selling, General and Administrative Expense | 5.33M | ||
| Operating Income | -19.71M | ||
| Net Income | -17.64M | ||
| Net Income Common Stock | -17.64M | ||
| Net Income Common Stock (USD) | -17.64M | ||
| Consolidated Income | -17.64M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -17.64M | ||
| Earning Before Interest & Taxes (USD) | -17.64M | ||
| Weighted Average Shares | 61.43M | ||
| Weighted Average Shares Diluted | 61.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.77M | ||
| Cash and Equivalents (USD) | 12.77M | ||
| Investments | 210.05M | ||
| Investments Current | 210.05M | ||
| Current Assets | 227.05M | ||
| Property, Plant & Equipment Net | 3.39M | ||
| Total Assets | 230.44M | ||
| Total Debt | 2.20M | ||
| Current Liabilities | 10.19M | ||
| Debt Non-Current | 2.20M | ||
| Total Liabilities | 12.39M | ||
| Accumulated Retained Earnings (Deficit) | -314.64M | ||
| Accumulated Other Comprehensive Income | -268.00K | ||
| Shareholders Equity | 218.05M | ||
| Shareholders Equity (USD) | 218.05M | ||
| Assets Non-Current | 3.39M | ||
| Total Debt (USD) | 2.20M | ||
| Liabilities Non-Current | 2.20M | ||
| Trade and Non-Trade Payables | 2.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 226.00K | ||
| Net Cash Flow from Financing | 19.93M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.09M | ||
| Issuance (Purchase) of Equity Shares | 19.93M | ||
| Net Cash Flow from Investing | -7.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.59M | ||
| Net Cash Flow from Operations | -16.43M | ||
| Share Based Compensation | 3.92M | ||